Breaking News

Theranos whistleblower on Elizabeth Holmes’ second act

May 18, 2025
avatar-torie-bosch
First Opinion editor

When I saw the news that the partner of Elizabeth Holmes — she of the black turtleneck, subject of podcasts and books and a Hulu miniseries, perhaps the most famous convicted fraudster in biotech, cellblock buddy of a Real Housewife of Salt Lake City — a was launching a diagnostics company that sounds an awful lot like Theranos, I literally gasped. That couldn't be right, could it?

But Tyler Shultz wasn't surprised.

In First Opinion this week, the Theranos whistleblower writes, "Anyone who thought this story was over doesn't know Elizabeth and her ability to craft a narrative." In his sharp (and quite funny) essay, Shultz shares his insider's view of Holmes and speculates about the goal here. As he writes, "While Elizabeth has no legal affiliation with the company, her fingerprints and pricks are all over it."

***

On Wednesday, I'm heading on vacation. If you are planning to submit a potential First Opinion piece soon and it's not extremely time-sensitive, I suggest waiting until I'm back after May 29. Also, while I won't have much time to relax (the 14-month-old is coming along — spare a thought for us, and for the other passengers), I welcome recommendations for light reads and good movies or TV shows for the plane.

Recommendation of the week: It seems like there can't possibly be left to say about HHS Secretary Robert F. Kennedy Jr., but Malcolm Gladwell managed it on his podcast "Revisionist History." The episode is called "The RFK Jr. Problem."



Wikimedia Commons

'What do we do with uncertainty?' A former CDC director's advice to new physicians and scientists

Former CDC Director Rochelle Walensky offers powerful advice to 2025 medical school and Ph.D. graduates in a WashU Medicine commencement address.

By Rochelle Walensky


STAT+ | Science is under attack. So I'm taking RFK Jr. to court

Harvard's Brittany Charlton, in STAT First Opinion essay, explains why she sued RFK Jr. over defunded LGBTQ+ programs: "It's about science and democracy."

By Brittany Charlton


What's missing from the WHO Pandemic Treaty

The WHO Pandemic Treaty reflects a global health system still reliant on charity and unrealistic optimism.

By Stephanie Psaki and Ashish K. Jha


Surgeon general nominee Casey Means, at left, and journalist Megyn Kelly, attending the confirmation hearing for Robert F. Kennedy Jr. for health secretary in January.
Ben Curtis/AP

STAT+ | Why Casey Means could be the right pick for surgeon general

MAHA's Casey Means' youth and focus on metabolic health and obesity is what the country needs from the surgeon general.

By Marc Siegel


STAT+ | A former surgeon general calls on the Senate to carefully consider the new nominee

The nation's health and safety depend on the competence and credibility of its surgeon general, according to former Trump Surgeon General Jerome Adams.

By Jerome Adams


I was a Theranos whistleblower. Here's what I think Elizabeth Holmes is up to

STAT First Opinion essay: Tyler Shultz says he always knew Elizabeth Holmes would have a second act, "shocked it's starting while she's still behind bars."

By Tyler Shultz


Leigh Vogel/Getty Images for Caring Across Generations

STAT+ | How Medicaid can innovate in the DOGE era

AI, innovative programs, and the integration of social and medical needs can let Medicaid better serve patients while remaining fiscally responsible.

By Nate Favini, Andrey Ostrovsky, and Neil Batlivala


STAT+ | The FDA is embracing AI boldly. Now it must show what responsible innovation looks like

As the FDA embraces AI, it must fiercely protect the autonomy and integrity of its reviewers.

By Jennifer Goldsack


A libertarian vision for U.S. health care

An expert says that a market-based approach to health care would provide better care for less money.

By Torie Bosch


Adobe

Can dying people really will their body to stay alive for a final event?

Can the human body hold on long enough to let the person make it to one final birthday, the birth of a grandchild, or a holiday?

By Arjun Sharma


Ensuring most-favored nation drug pricing doesn't sicken us

If the U.S. rationalizes how it pays for medicines, consumers, employers, and government payers would see fair prices.

By Darius Lakdawalla and Dana P. Goldman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments